RJA
BAK icon

Raymond James & Associates’s Braskem BAK Stock Holding History

Raymond James & Associates’s Portfolio BAK Stock Details BAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-67,506
Closed -$435K – 3996
2024
Q2 		$435K Sell
67,506
-24,680
-27% -$196K ﹤0.01% 3153
2024
Q1 		$971K Buy
+92,186
New +$752K ﹤0.01% 2612
2023
Q1 		– Sell
-12,920
Closed -$119K – 3885
2022
Q4 		$119K Buy
+12,920
New +$144K ﹤0.01% 3602

Other funds holding BAK

OCM
Oaktree Capital Management Los Angeles, California $6.56B AUM 42.97% 1-Year Est. Return
MPM
MBB Public Markets Chicago, Illinois $839M AUM 20.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
CC
Covalis Capital London, United Kingdom $1.63B AUM 27.84% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Optiver Holding
Optiver Holding Amsterdam, Netherlands $289B AUM 33.63% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Raymond James & Associates's BAK Position: Q3 2024 in Review

Raymond James & Associates sold out of Braskem (BAK) in Q3 2024, closing a stake of 67,506 shares — an estimated $435K sold.

Raymond James & Associates first reported a position in BAK in Q4 2022 and held it in 3 quarters. The position peaked at $971K in Q1 2024. 64 funds tracked by Wall St. Rank hold BAK as of Q3 2024.

  • Raymond James & Associates reported no remaining Braskem position as of Q3 2024 after selling out during the quarter.
  • Raymond James & Associates sold 67,506 Braskem shares in Q3 2024, an estimated $435K.
  • Raymond James & Associates first reported a position in Braskem in Q4 2022 and held it in 3 quarters.
  • Raymond James & Associates's Braskem position peaked at $971K in Q1 2024.
  • 64 funds tracked by Wall St. Rank held Braskem as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.